Related Experiment Video

Updated: Oct 18, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.8K

Cholesterol-Lowering Drugs on Akt Signaling for Prevention of Tumorigenesis

Navneet Kumar1, Chandi C Mandal2

  • 1Department of Biochemistry, All India Institute of Medical Sciences, Bhopal, India.

Frontiers in Genetics
|October 4, 2021
PubMed

Insights

Cholesterol accumulation fuels cancer. Cholesterol-lowering drugs target Akt signaling pathways, showing promise in preventing cancer progression and therapy resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cholesterol accumulates in cancer cells, and its metabolic dysregulation is linked to tumor development and progression.
  • Akt, a key kinase, regulates crucial cellular processes like proliferation, metabolism, and apoptosis, and is frequently dysregulated in cancers.
  • Cholesterol-lowering drugs have demonstrated potential in cancer prevention and treatment, influencing cancer cell signaling.

Purpose of the Study:

  • To review the role of cholesterol metabolism in cancer.
  • To examine the impact of cholesterol-lowering drugs on cancer.
  • To elucidate the relationship between cholesterol-lowering drugs, Akt signaling, and cancer therapy resistance.

Main Methods:

  • Literature review of studies on cholesterol metabolism in cancer.
  • Analysis of research on cholesterol-lowering drugs' effects on cancer cells.
  • Examination of Akt signaling pathways modulated by cholesterol-lowering drugs.

Main Results:

  • Cholesterol dysregulation is implicated in tumor progression.
  • Cholesterol-lowering drugs exhibit anticancer activities.
  • These drugs modulate Akt expression and activation, impacting pathways like PTEN/Akt and PI3k/Akt.

Conclusions:

  • Targeting Akt signaling with cholesterol-lowering drugs is a potential therapeutic strategy for cancer.
  • Understanding these mechanisms can aid in preventing therapy resistance and metastasis.
  • Cholesterol-lowering drugs offer a promising avenue for cancer prevention and treatment by modulating Akt pathways.
Keywords:
Akt signalingcancercholesterolcholesterol-lowering drugsfenofibratestatins

More Related Videos

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.4K
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

16.8K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
966
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
763